Patent · US Active

Recombinant vaccines and use thereof

US8178653B2 · kind B2 · utility

9Cited by

0References

4Claims

0Family size

Assignee

BioNTech AG · DE

Inventors

Ozlem Tureci · Homburg, DE
Ugur Sahin · Mainz, DE
Sebastian Kreiter · Mainz, DE

Key dates

Filing date	Oct 13, 2004
Grant date	May 15, 2012
Priority date	—
Expiry date	May 31, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/03
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to fusion molecules of antigens, the nucleic acids coding therefor and the use of such fusion molecules and nucleic acids. In particular, said invention relates to fusion molecules, comprising an antigen and the transmembrane region and cytoplasmic region of a MHC molecule and/or the cytoplasmic region of a MHC or a SNARE molecule.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.